Evaluation of Vaccine Immunogenicity—Correlates to Real-World Protection: Influenza

Author:

Laszlofy Csaba1ORCID,Fazekas Gyorgy2,Barath Zoltan1,Vajo Zoltan3ORCID

Affiliation:

1. Department of Prosthodontics, Faculty of Dentistry, University of Szeged, 6720 Szeged, Hungary

2. Fluart Innovations Ltd., 2097 Pilisborosjeno, Hungary

3. Department of Family Medicine, Semmelweis University Medical School, 1085 Budapest, Hungary

Abstract

Recent events highlighted that, despite decades of studying vaccine immunogenicity and efforts toward finding correlates of protection, evaluating real-world vaccine efficacy as well as establishing meaningful licensing criteria still represents a significant challenge. In this paper, we review all aspects of influenza vaccine immunogenicity, including animal and human challenge studies, humoral and cellular immunity parameters, and their potential correlation with real-life protection from disease.

Publisher

MDPI AG

Reference51 articles.

1. European Committee for Proprietary Medicinal Products (2023, December 07). Note for Guidance on Harmonization of Requirements for Influenza Vaccines, 12 March 1997 (CPMP/BWP/214/96). Available online: https://www.ema.europa.eu/en/documents/scientific-guideline/note-guidance-harmonisation-requirements-influenza-vaccines_en.pdf.

2. (2023, December 07). Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines. FDA, Available online: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-data-needed-support-licensure-seasonal-inactivated-influenza-vaccines.

3. Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines;Couch;Vaccine,2012

4. Stability of neuraminidase in inactivated influenza vaccines;Sultana;Vaccine,2014

5. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: Higher antibody and lower cell-mediated immune responses with advanced age;Skowronski;J. Infect. Dis.,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3